Brief: Phio Pharmaceuticals Presenting Data Showing Intasyl May Result In More Effective Cell Therapy For Hematological Malignancies
21/03/2024 11:42
March 21 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS PRESENTING DATA SHOWING INTASYL MAY
RESULT
IN MORE EFFECTIVE CELL THERAPY FOR HEMATOLOGICAL MALIGNANCIES
Source text for Eikon: ID:nGNX4kJ8lB
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing